Medication info

Hyun's Lidocaine Hydrochloride Injection 2%

Prescription medicationInjectionsIntravenous injection
Ingredient · strength
Lidocaine Hydrochloride Hydrate›21.33mg / 1mL
Manufacturer / importer
Huons Co., Ltd.
Appearance
The product is a colorless and transparent injectable solution in an ampule and vial.
Packaging
- Domestic Use: 5 mL × 20 ampules, 5 mL × 25 ampules, 20 mL × 10 vials - Export Use: 1.8 mL × 50, 100 ampules, 2 mL × 10 ampules, 5 mL × 10 ampules, 50 mL × 1, 10, 50, 100 vials, 5 mL × 10, 25 vials, 20 mL × 25 vials
Approval status
Active

MFDS item code 197900443 · Notified 1979.01.25 · Insurance code 670603485,670607491

Summary

Main use
Anesthesia (epidural, conduction, infiltration, etc.); treatment of ventricular arrhythmias
Who receives it
Adults
Adult administration
(Solution: 2% viscous) Adults: The recommended maximum single dose for healthy adults is 4.5 mg of lidocaine hydrochloride per kg of body weight, and under no circumstances should the total dose exceed 300 mg of lidocaine hydrochloride (15 mL of this product). For symptomatic treatment of irritation or inflammation of the oral or pharyngeal mucosa, administer 300 mg of lidocaine hydrochloride (15 mL of this product). For oral use, hold this product in the mouth and then spit it out; for pharyngeal use, it may be swallowed after holding it in the mouth. Do not reuse within 3 hours and do not use more than 8 times within 24 hours. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Gel: 2%) ○ Adults 1. Urethral anesthesia 1) Surface anesthesia of the male urethra: Instill 20 mL (400 mg of lidocaine hydrochloride), inserting 10 mL of this product (200 mg of lidocaine hydrochloride) slowly, apply a penile clamp to the corona for several minutes, and then instill the remaining amount. When anesthesia is particularly important, such as during catheterization or cystoscopy, a larger amount (e.g., 30-40 mL of this product) may be applied in 3-4 divided doses. 2) Surface anesthesia of the female urethra: Instill 5-10 mL of this product (100-200 mg of lidocaine hydrochloride). 2. During endoscopic examination: Instill 10-20 mL of this product (200-400 mg of lidocaine hydrochloride); when used for lubrication, apply a small amount to the instrument. 3. Lubrication for tracheal intubation: Immediately before insertion, apply approximately 5 mL of this product (100 mg of lidocaine hydrochloride) to the surface of the tube. Take care to prevent this product from entering the tube. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 0.5% for intramuscular use) Adults: Using the solvent for intramuscular use, inject 10-15 mg of lidocaine hydrochloride intramuscularly. Never use for intravenous injection. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 1%) [Anesthesia] ○ Adults 1. Epidural anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 100-200 mg 2. Nerve block (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 30-200 mg; 30-100 mg for supportive nerve block; up to 50 mg for intercostal nerve block 3. Infiltration anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 20-200 mg 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. [Medical use] ○ Adults 1. Single intravenous dose: Slowly inject 50-100 mg of lidocaine hydrochloride (1-2 mg/kg) intravenously over 1-2 minutes. If no effect occurs, administer the same dose after 5 minutes. If sustained effect is desired, the same dose may also be administered additionally at intervals of 10-20 minutes; however, the reference maximum dose within 1 hour is 300 mg. 2. Intravenous infusion: When a single intravenous dose is effective and sustained effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject lidocaine hydrochloride intravenously at a rate of 1-2 mg per minute. The infusion rate may be increased if necessary, but the maximum rate is 4 mg per minute. (Injection: 2%) [Anesthesia] ○ Adults 1. Epidural anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 200 mg 2. Nerve block (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 40-200 mg; 60-120 mg for supportive nerve block 3. Infiltration anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 40-200 mg 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. [Medical use] ○ Adults 1. Single intravenous dose: Slowly inject 50-100 mg of lidocaine hydrochloride (1-2 mg/kg) intravenously over 1-2 minutes. If no effect occurs, administer the same dose after 5 minutes. If sustained effect is desired, the same dose may also be administered additionally at intervals of 10-20 minutes; however, the reference maximum dose within 1 hour is 300 mg. 2. Intravenous infusion: When a single intravenous dose is effective and sustained effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject lidocaine hydrochloride intravenously at a rate of 1-2 mg per minute. The infusion rate may be increased if necessary, but the maximum rate is 4 mg per minute. (Injection: 0.5%) ○ Adults 1. Epidural anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 25-150 mg; 25-100 mg for sympathetic nerve block 2. Nerve block (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 15-200 mg; 15-50 mg for supportive nerve block; up to 25 mg for intercostal nerve block 3. Infiltration anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 10-200 mg 4. Intravenous regional anesthesia of the extremities: Do not exceed 200 mg of bupivacaine hydrochloride. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 4%) ○ Adults 1. Surface anesthesia (for use on mucous membranes such as the oral cavity, throat, airway, and urethra): The maximum single dose for healthy adults is 4.5 mg of lidocaine hydrochloride per kg of body weight, and the total dose should not exceed 300 mg of lidocaine hydrochloride. Apply or spray an appropriate amount, referring to the following. 1) For local anesthesia via a transtracheal bronchoscope, inject 80-120 mg of lidocaine hydrochloride (2-3 mL of this product) through a needle of sufficient size to allow rapid injection. Occasionally, the pharynx may be sprayed to achieve complete analgesia, but the total amount administered by injection and spray should not exceed 200 mg of lidocaine hydrochloride (5 mL of this product) or 3 mL per kg of body weight. 2) Topical application: Spray 40-200 mg of lidocaine hydrochloride (1-5 mL of this product) into the pharynx during laryngopharyngeal examination, bronchoscopy, and endotracheal intubation. 2. (Diluted to 0.5~2%) Epidural anesthesia, nerve block, and infiltration anesthesia: The reference maximum dose is 200 mg of lidocaine hydrochloride per dose. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition.

Ingredients

Manufacturer
Huons Co., Ltd.

Efficacy & effects

Anesthesia (epidural, conduction, infiltration, etc.); treatment of ventricular arrhythmias

  • Irritation of oral mucosa
  • irritation of pharyngeal mucosa
  • oral inflammation
  • pharyngeal inflammation
  • gag reflex
View approved original text

This medication is used in various forms and is effective for anesthesia and pain relief in different areas. The 2% viscous solution is used for local anesthesia during irritation or inflammation of the oral and pharyngeal mucosa, and also helps suppress the gag reflex during dental X-rays or impressions. The 2% gel provides surface anesthesia and lubrication during cystoscopy, gastroscopy, bronchoscopy, rectoscopy, and intubation, and is effective in relieving pain from cystitis and urethritis. The injectable form is used for reducing pain during intramuscular injection, epidural anesthesia, regional anesthesia, infiltration anesthesia, and surface anesthesia, and also for treating ventricular arrhythmias. Overall, this medication is widely used for anesthesia and pain relief.

How it is given

Adult administration

(Solution: 2% viscous) Adults: The recommended maximum single dose for healthy adults is 4.5 mg of lidocaine hydrochloride per kg of body weight, and under no circumstances should the total dose exceed 300 mg of lidocaine hydrochloride (15 mL of this product). For symptomatic treatment of irritation or inflammation of the oral or pharyngeal mucosa, administer 300 mg of lidocaine hydrochloride (15 mL of this product). For oral use, hold this product in the mouth and then spit it out; for pharyngeal use, it may be swallowed after holding it in the mouth. Do not reuse within 3 hours and do not use more than 8 times within 24 hours. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Gel: 2%) ○ Adults 1. Urethral anesthesia 1) Surface anesthesia of the male urethra: Instill 20 mL (400 mg of lidocaine hydrochloride), inserting 10 mL of this product (200 mg of lidocaine hydrochloride) slowly, apply a penile clamp to the corona for several minutes, and then instill the remaining amount. When anesthesia is particularly important, such as during catheterization or cystoscopy, a larger amount (e.g., 30-40 mL of this product) may be applied in 3-4 divided doses. 2) Surface anesthesia of the female urethra: Instill 5-10 mL of this product (100-200 mg of lidocaine hydrochloride). 2. During endoscopic examination: Instill 10-20 mL of this product (200-400 mg of lidocaine hydrochloride); when used for lubrication, apply a small amount to the instrument. 3. Lubrication for tracheal intubation: Immediately before insertion, apply approximately 5 mL of this product (100 mg of lidocaine hydrochloride) to the surface of the tube. Take care to prevent this product from entering the tube. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 0.5% for intramuscular use) Adults: Using the solvent for intramuscular use, inject 10-15 mg of lidocaine hydrochloride intramuscularly. Never use for intravenous injection. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 1%) [Anesthesia] ○ Adults 1. Epidural anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 100-200 mg 2. Nerve block (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 30-200 mg; 30-100 mg for supportive nerve block; up to 50 mg for intercostal nerve block 3. Infiltration anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 20-200 mg 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. [Medical use] ○ Adults 1. Single intravenous dose: Slowly inject 50-100 mg of lidocaine hydrochloride (1-2 mg/kg) intravenously over 1-2 minutes. If no effect occurs, administer the same dose after 5 minutes. If sustained effect is desired, the same dose may also be administered additionally at intervals of 10-20 minutes; however, the reference maximum dose within 1 hour is 300 mg. 2. Intravenous infusion: When a single intravenous dose is effective and sustained effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject lidocaine hydrochloride intravenously at a rate of 1-2 mg per minute. The infusion rate may be increased if necessary, but the maximum rate is 4 mg per minute. (Injection: 2%) [Anesthesia] ○ Adults 1. Epidural anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 200 mg 2. Nerve block (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 40-200 mg; 60-120 mg for supportive nerve block 3. Infiltration anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 40-200 mg 4. Surface anesthesia: Apply or spray an appropriate amount Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. [Medical use] ○ Adults 1. Single intravenous dose: Slowly inject 50-100 mg of lidocaine hydrochloride (1-2 mg/kg) intravenously over 1-2 minutes. If no effect occurs, administer the same dose after 5 minutes. If sustained effect is desired, the same dose may also be administered additionally at intervals of 10-20 minutes; however, the reference maximum dose within 1 hour is 300 mg. 2. Intravenous infusion: When a single intravenous dose is effective and sustained effect is desired, administer by intravenous infusion under continuous electrocardiographic monitoring. Inject lidocaine hydrochloride intravenously at a rate of 1-2 mg per minute. The infusion rate may be increased if necessary, but the maximum rate is 4 mg per minute. (Injection: 0.5%) ○ Adults 1. Epidural anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 25-150 mg; 25-100 mg for sympathetic nerve block 2. Nerve block (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 15-200 mg; 15-50 mg for supportive nerve block; up to 25 mg for intercostal nerve block 3. Infiltration anesthesia (reference maximum dose: 200 mg of lidocaine hydrochloride per dose): 10-200 mg 4. Intravenous regional anesthesia of the extremities: Do not exceed 200 mg of bupivacaine hydrochloride. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition. (Injection: 4%) ○ Adults 1. Surface anesthesia (for use on mucous membranes such as the oral cavity, throat, airway, and urethra): The maximum single dose for healthy adults is 4.5 mg of lidocaine hydrochloride per kg of body weight, and the total dose should not exceed 300 mg of lidocaine hydrochloride. Apply or spray an appropriate amount, referring to the following. 1) For local anesthesia via a transtracheal bronchoscope, inject 80-120 mg of lidocaine hydrochloride (2-3 mL of this product) through a needle of sufficient size to allow rapid injection. Occasionally, the pharynx may be sprayed to achieve complete analgesia, but the total amount administered by injection and spray should not exceed 200 mg of lidocaine hydrochloride (5 mL of this product) or 3 mL per kg of body weight. 2) Topical application: Spray 40-200 mg of lidocaine hydrochloride (1-5 mL of this product) into the pharynx during laryngopharyngeal examination, bronchoscopy, and endotracheal intubation. 2. (Diluted to 0.5~2%) Epidural anesthesia, nerve block, and infiltration anesthesia: The reference maximum dose is 200 mg of lidocaine hydrochloride per dose. Adjust the dose appropriately according to age, area to be anesthetized, site, tissue, symptoms, constitution, and general condition.

Precautions

This drug is a glass ampule injectable solution, so care must be taken when cutting the container to avoid the introduction of glass fragments. Special caution is needed when used in children or the elderly. This drug should not be used in certain patients. For example, it should not be administered to patients with severe bleeding or in a state of shock, patients with inflammation at the injection site or septicemia, and patients allergic to this drug or similar local anesthetics. Caution is advised when administering to patients with central nervous system diseases, pregnant women, elderly individuals, patients with severe hypertension, and those with severe spinal deformities. This medication can rarely cause serious side effects such as shock, hypotension, and respiratory depression; therefore, the patient's condition should be closely monitored. Additionally, malignant hyperthermia may occur rarely, characterized by a rapid increase in body temperature, muscle rigidity, and arrhythmias. If such symptoms appear, administration should be stopped immediately and appropriate treatment provided. Since this medication affects the central nervous system, symptoms like tremors, seizures, drowsiness, dizziness, and nausea may occur, so appropriate measures should be taken immediately upon noticing such symptoms. When using this drug, allergic reactions may manifest as hives or edema, requiring caution, and in severe cases, anaphylaxis may occur. Before use, it is essential to check the patient's overall condition carefully and to use the lowest concentration and minimum dosage possible. Care should be taken to use only small amounts when injecting into vascular areas, ensuring that the injection needle does not enter a blood vessel. When used in conjunction with vasoconstrictors, the risk of side effects may be increased in certain patients, so careful consideration of its administration is necessary. This medication should only be administered to pregnant women or women of childbearing potential when the benefits outweigh the risks. Elderly patients may experience slower metabolism of this drug, making side effects more likely, so dosage adjustment and condition monitoring are required. This medication is not for ophthalmic use and careful attention must be paid as long-term use at high concentrations may pose a carcinogenic risk. Additionally, this medication should be administered cautiously in patients with severely impaired liver and kidney function or cardiac conduction disorders, avoiding overdose and frequently monitoring blood pressure and electrocardiography. Caution is needed when combining with other medications as drug concentrations may change due to interactions.

Side effects

  • Shock
  • hypotension
  • facial pallor
  • abnormal pulse
  • respiratory depression
  • unexplained tachycardia
  • arrhythmia
  • blood pressure fluctuations
  • sudden rise in body temperature
  • muscle rigidity
Show 25 more
  • dark red coloration of blood
  • hyperventilation
  • sweating
  • acidosis
  • hyperkalemia
  • myoglobinuria
  • tremors
  • convulsions
  • drowsiness
  • anxiety
  • agitation
  • neglect
  • dizziness
  • nausea
  • vomiting
  • urticaria
  • edema
  • anaphylactic reaction
  • prolongation of PQ interval
  • increase in QRS width
  • bradycardia
  • cardiac arrest
  • delusions
  • euphoria
  • numbness

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent contact with air and is best kept at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the medication's effectiveness.

Appearance and packaging

Appearance

The product is a colorless and transparent injectable solution in an ampule and vial.

Package unit

- Domestic Use: 5 mL × 20 ampules, 5 mL × 25 ampules, 20 mL × 10 vials - Export Use: 1.8 mL × 50, 100 ampules, 2 mL × 10 ampules, 5 mL × 10 ampules, 50 mL × 1, 10, 50, 100 vials, 5 mL × 10, 25 vials, 20 mL × 25 vials

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.